MondayMay 24, 2010 12:41 pm
Nanoviricides Inc. is a development stage company creating special purpose nanomaterials for viral therapy. The company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and dismantle them. The company is developing drugs against a wide variety of viral diseases. The company filed its quarterly report with the Securities and Exchange Commission (SEC) on May 20, 2010. Nanoviricides reported that it had approximately $2.85 million in cash and $305,000 in prepaid expenses as of the end of the quarter – March 31, 2010. The company also reported it spent approximately $1.583 million in research and…
Continue Reading